MedTrace Logo

Efficacy of Topiramate for Hospitalized Patients With Alcoholism

NCT01145677 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2011-06-23

No results posted yet for this study

Summary

This is a 12-Week, randomized controlled study of topiramate in hospitalized patients with alcoholism

Conditions

  • Alcohol Dependence

Interventions

DRUG

Topiramate

Topiramate 100-300 mg/day orally twice per day

Sponsors & Collaborators

  • Chiang Mai University

    lead OTHER

Principal Investigators

  • Surinporn Likhitsathian, MD · Department of Psychiatry, Faculty of Medicine, Chiang Mai University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-03-31
Completion
2011-06-30

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01145677 on ClinicalTrials.gov